PMC:7253235 / 40530-41296 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1376","span":{"begin":84,"end":94},"obj":"Species"},{"id":"1377","span":{"begin":637,"end":645},"obj":"Species"},{"id":"1390","span":{"begin":63,"end":69},"obj":"Disease"},{"id":"1391","span":{"begin":207,"end":213},"obj":"Disease"},{"id":"1392","span":{"begin":338,"end":346},"obj":"Disease"},{"id":"1393","span":{"begin":547,"end":552},"obj":"Disease"}],"attributes":[{"id":"A1376","pred":"tao:has_database_id","subj":"1376","obj":"Tax:9606"},{"id":"A1377","pred":"tao:has_database_id","subj":"1377","obj":"Tax:9606"},{"id":"A1390","pred":"tao:has_database_id","subj":"1390","obj":"MESH:D009369"},{"id":"A1391","pred":"tao:has_database_id","subj":"1391","obj":"MESH:D009369"},{"id":"A1392","pred":"tao:has_database_id","subj":"1392","obj":"MESH:C000657245"},{"id":"A1393","pred":"tao:has_database_id","subj":"1393","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"• Implementation of universal PPE and social distancing during cancer treatments in outpatient/inpatient settings, and with family members/caretakers\n• Weighing risk-benefit of postponing/delaying timing of cancer treatments/surgery to minimize exposure to inpatient healthcare setting\n• Preoperative/procedural screening and testing for COVID-19\n• Telemedicine for routine follow-up cardio-oncology/oncology visits unless clinically symptomatic\n• Research efforts investigating earlier utilization of immune system restorative measures post anti-tumor therapy\n• Consideration of delaying myeloablative therapies and immunotherapies for patients in clinical remission if possible\n• Consideration of minimizing surveillance/staging imaging during and after treatments"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T117","span":{"begin":502,"end":515},"obj":"Body_part"}],"attributes":[{"id":"A117","pred":"fma_id","subj":"T117","obj":"http://purl.org/sig/ont/fma/fma9825"}],"text":"• Implementation of universal PPE and social distancing during cancer treatments in outpatient/inpatient settings, and with family members/caretakers\n• Weighing risk-benefit of postponing/delaying timing of cancer treatments/surgery to minimize exposure to inpatient healthcare setting\n• Preoperative/procedural screening and testing for COVID-19\n• Telemedicine for routine follow-up cardio-oncology/oncology visits unless clinically symptomatic\n• Research efforts investigating earlier utilization of immune system restorative measures post anti-tumor therapy\n• Consideration of delaying myeloablative therapies and immunotherapies for patients in clinical remission if possible\n• Consideration of minimizing surveillance/staging imaging during and after treatments"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T54","span":{"begin":502,"end":515},"obj":"Body_part"}],"attributes":[{"id":"A54","pred":"uberon_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"• Implementation of universal PPE and social distancing during cancer treatments in outpatient/inpatient settings, and with family members/caretakers\n• Weighing risk-benefit of postponing/delaying timing of cancer treatments/surgery to minimize exposure to inpatient healthcare setting\n• Preoperative/procedural screening and testing for COVID-19\n• Telemedicine for routine follow-up cardio-oncology/oncology visits unless clinically symptomatic\n• Research efforts investigating earlier utilization of immune system restorative measures post anti-tumor therapy\n• Consideration of delaying myeloablative therapies and immunotherapies for patients in clinical remission if possible\n• Consideration of minimizing surveillance/staging imaging during and after treatments"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T405","span":{"begin":63,"end":69},"obj":"Disease"},{"id":"T406","span":{"begin":207,"end":213},"obj":"Disease"},{"id":"T407","span":{"begin":338,"end":346},"obj":"Disease"},{"id":"T408","span":{"begin":547,"end":552},"obj":"Disease"}],"attributes":[{"id":"A405","pred":"mondo_id","subj":"T405","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A406","pred":"mondo_id","subj":"T406","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A407","pred":"mondo_id","subj":"T407","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A408","pred":"mondo_id","subj":"T408","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"• Implementation of universal PPE and social distancing during cancer treatments in outpatient/inpatient settings, and with family members/caretakers\n• Weighing risk-benefit of postponing/delaying timing of cancer treatments/surgery to minimize exposure to inpatient healthcare setting\n• Preoperative/procedural screening and testing for COVID-19\n• Telemedicine for routine follow-up cardio-oncology/oncology visits unless clinically symptomatic\n• Research efforts investigating earlier utilization of immune system restorative measures post anti-tumor therapy\n• Consideration of delaying myeloablative therapies and immunotherapies for patients in clinical remission if possible\n• Consideration of minimizing surveillance/staging imaging during and after treatments"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T307","span":{"begin":326,"end":333},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T308","span":{"begin":502,"end":515},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"• Implementation of universal PPE and social distancing during cancer treatments in outpatient/inpatient settings, and with family members/caretakers\n• Weighing risk-benefit of postponing/delaying timing of cancer treatments/surgery to minimize exposure to inpatient healthcare setting\n• Preoperative/procedural screening and testing for COVID-19\n• Telemedicine for routine follow-up cardio-oncology/oncology visits unless clinically symptomatic\n• Research efforts investigating earlier utilization of immune system restorative measures post anti-tumor therapy\n• Consideration of delaying myeloablative therapies and immunotherapies for patients in clinical remission if possible\n• Consideration of minimizing surveillance/staging imaging during and after treatments"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T220","span":{"begin":63,"end":69},"obj":"Phenotype"},{"id":"T221","span":{"begin":207,"end":213},"obj":"Phenotype"},{"id":"T222","span":{"begin":391,"end":399},"obj":"Phenotype"},{"id":"T223","span":{"begin":400,"end":408},"obj":"Phenotype"},{"id":"T224","span":{"begin":547,"end":552},"obj":"Phenotype"}],"attributes":[{"id":"A220","pred":"hp_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A221","pred":"hp_id","subj":"T221","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A222","pred":"hp_id","subj":"T222","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A223","pred":"hp_id","subj":"T223","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A224","pred":"hp_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"• Implementation of universal PPE and social distancing during cancer treatments in outpatient/inpatient settings, and with family members/caretakers\n• Weighing risk-benefit of postponing/delaying timing of cancer treatments/surgery to minimize exposure to inpatient healthcare setting\n• Preoperative/procedural screening and testing for COVID-19\n• Telemedicine for routine follow-up cardio-oncology/oncology visits unless clinically symptomatic\n• Research efforts investigating earlier utilization of immune system restorative measures post anti-tumor therapy\n• Consideration of delaying myeloablative therapies and immunotherapies for patients in clinical remission if possible\n• Consideration of minimizing surveillance/staging imaging during and after treatments"}

{"project":"LitCovid-sentences","denotations":[{"id":"T256","span":{"begin":150,"end":285},"obj":"Sentence"},{"id":"T257","span":{"begin":286,"end":346},"obj":"Sentence"},{"id":"T258","span":{"begin":347,"end":445},"obj":"Sentence"},{"id":"T259","span":{"begin":446,"end":560},"obj":"Sentence"},{"id":"T260","span":{"begin":561,"end":679},"obj":"Sentence"},{"id":"T261","span":{"begin":680,"end":766},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Implementation of universal PPE and social distancing during cancer treatments in outpatient/inpatient settings, and with family members/caretakers\n• Weighing risk-benefit of postponing/delaying timing of cancer treatments/surgery to minimize exposure to inpatient healthcare setting\n• Preoperative/procedural screening and testing for COVID-19\n• Telemedicine for routine follow-up cardio-oncology/oncology visits unless clinically symptomatic\n• Research efforts investigating earlier utilization of immune system restorative measures post anti-tumor therapy\n• Consideration of delaying myeloablative therapies and immunotherapies for patients in clinical remission if possible\n• Consideration of minimizing surveillance/staging imaging during and after treatments"}